Zolamide

CAS No. 14949-00-9

Zolamide( 5-Amino-TDSNH2 | CL 5343 | Tio-urasin | Zolamide )

Catalog No. M27384 CAS No. 14949-00-9

Zolamide may be used to prevent altitude sickness and reduce the symptoms.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 37 In Stock
25MG 49 In Stock
50MG 67 In Stock
100MG 95 In Stock
200MG 140 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Zolamide
  • Note
    Research use only, not for human use.
  • Brief Description
    Zolamide may be used to prevent altitude sickness and reduce the symptoms.
  • Description
    Zolamide may be used to prevent altitude sickness and reduce the symptoms.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    5-Amino-TDSNH2 | CL 5343 | Tio-urasin | Zolamide
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    acetylcholinesterase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    14949-00-9
  • Formula Weight
    180.2
  • Molecular Formula
    C2H4N4O2S2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    Nc1nnc(s1)S(N)(=O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Han J, Jiang S, Cui X, Sun Y, Li G, Zhang J, Fawcett JP, Gu J. Quantitation of the tacrine analogue octahydroaminoacridine in human plasma by liquid chromatography-tandem mass spectrometry. J Pharm Biomed Anal. 2009 Sep 8;50(2):171-4. doi: 10.1016/j.jpba.2009.03.022. Epub 2009 Apr 1. PubMed PMID: 19395215.
molnova catalog
related products
  • Folinic Acid Calcium...

    Folinic Acid is a reduced folic acid, which is used in combination with other chemotherapy drugs.

  • NH2-PEG6-C1-Boc

    NH2-PEG6-C1-Boc is a PEG-based PROTAC linker that can be used in the synthesis of PROTACs.

  • SPR741

    SPR741, formerly NAB741 (12), is a cationic peptide derived from polymyxin B and is one such potentiator molecule that is under development for the treatment of serious Gram-negative bacterial infections.